SIRPα on CD11c


Journal

European journal of immunology
ISSN: 1521-4141
Titre abrégé: Eur J Immunol
Pays: Germany
ID NLM: 1273201

Informations de publication

Date de publication:
10 2020
Historique:
received: 17 09 2019
revised: 12 04 2020
pubmed: 22 5 2020
medline: 12 1 2021
entrez: 22 5 2020
Statut: ppublish

Résumé

Signal regulatory protein α (SIRPα) is expressed predominantly on type 2 conventional dendritic cells (cDC2s) and macrophages. We previously showed that mice systemically lacking SIRPα were resistant to experimental autoimmune encephalomyelitis (EAE). Here, we showed that deletion of SIRPα in CD11c

Identifiants

pubmed: 32438469
doi: 10.1002/eji.201948410
doi:

Substances chimiques

CD11c Antigen 0
Ptpns1 protein, mouse 0
Receptors, Immunologic 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1560-1570

Informations de copyright

© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Références

Dendrou, C. A., Fugger, L. and Friese, M. A., Immunopathology of multiple sclerosis. Nat. Rev. Immunol. 2015. 15: 545-558.
Steinman, L., Immunology of relapse and remission in multiple sclerosis. Annu. Rev. Immunol. 2014. 32: 257-281.
Simmons, S. B., Pierson, E. R., Lee, S. Y. and Goverman, J. M., Modeling the heterogeneity of multiple sclerosis in animals. Trends Immunol. 2013. 34: 410-422.
Steinman, R. M., Decisions about dendritic cells: past, present, and future. Annu. Rev. Immunol. 2012. 30: 1-22.
Eisenbarth, S. C., Dendritic cell subsets in T-cell programming: location dictates function. Nat. Rev. Immunol. 2019. 19: 89-103.
Mildner, A. and Jung, S., Development and function of dendritic cell subsets. Immunity. 2014. 40: 642-656.
Reizis, B., Bunin, A., Ghosh, H. S., Lewis, K. L. and Sisirak, V., Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol. 2011. 29: 163-183.
Steinman, R. M., Hawiger, D. and Nussenzweig, M. C., Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003. 21: 685-711.
Worbs, T., Hammerschmidt, S. I. and Förster, R., Dendritic cell migration in health and disease. Nat. Rev. Immunol. 2017. 17: 30-48.
Paterka, M., Siffrin, V., Voss, J. O., Werr, J., Hoppmann, N., Gollan, R., Belikan, P. et al., Gatekeeper role of brain antigen-presenting CD11c+ cells in neuroinflammation. EMBO J. 2016. 35: 89-101.
Bartholomäus, I., Kawakami, N., Odoardi, F., Schläger, C., Miljkovic, D., Ellwart, J. W., Klinkert, W. E .F. et al., Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature. 2009. 462: 94-98.
Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J. et al., Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 2005. 11: 328-334.
Voet, S., Prinz, M. and van Loo, G., Microglia in central nervous system inflammation and multiple sclerosis pathology. Trends Mol. Med. 2019. 25: 112-123.
Matozaki, T., Murata, Y., Okazawa, H. and Ohnishi, H., Functions and molecular mechanisms of the CD47-SIRPα signalling pathway. Trends Cell Biol. 2009, 19: 72-80.
Barclay, A. N. and van den Berg, T. K., The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target. Annu. Rev. Immunol. 2014. 32: 25-50.
Murata, Y., Saito, Y., Kotani, T. and Matozaki, T., CD47-signal regulatory protein α signaling system and its application to cancer immunotherapy. Cancer Sci. 2018. 109: 2349-2357.
Tomizawa, T., Kaneko, Y., Kaneko, Y., Saito, Y., Ohnishi, H., Okajo, J., Okuzawa, C. et al., Resistance to experimental autoimmune encephalomyelitis and impaired T cell priming by dendritic cells in Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 mutant mice. J. Immunol. 2007. 179: 869-877.
Murata, Y., Saito, Y., Kaneko, T., Kotani, T., Kaneko, Y., Ohnishi, H. and Matozaki, T., Autoimmune animal models in the analysis of the CD47-SIRPα signaling pathway. Methods. 2014. 65: 254-259.
Mrdjen, D., Pavlovic, A., Hartmann, F. J., Schreiner, B., Utz, S. G., Leung, B. P., Lelios, I. et al., High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity. 2018. 48: 380-395.
Washio, K., Kotani, T., Saito, Y., Respatika, D., Murata, Y., Kaneko, Y., Okazawa, H. et al., Dendritic cell SIRPα regulates homeostasis of dendritic cells in lymphoid organs. Genes Cells. 2015. 20: 451-463.
Cua, D. J., Sherlock, J., Chen, Y, Murphy, C. A., Joyce, B., Seymour, B., Lucian, L. et al., Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003. 421: 744-748.
Serada, S., Fujimoto, M., Mihara, M., Koike, N., Ohsugi, Y., Nomura, S., Yoshida, H. et al., IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 2008. 105: 9041-9046.
Hernandez-Mir, G. and McGeachy, M. J., CD73 is expressed by inflammatory Th17 cells in experimental autoimmune encephalomyelitis but does not limit differentiation or pathogenesis. PLoS ONE. 2017. 12: e0173655.
Heink, S., Yogev, N., Garbers, C., Herwerth, M., Aly, L., Gasperi, C., Husterer, V. et al., Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells. Nat. Immunol. 2017. 18: 74-85.
Ko, H. -J., Brady, J. L., Ryg-Cornejo, V., Hansen, D. S., Vremec, D., Shortman, K., Zhan, Y. et al., GM-CSF-responsive monocyte-derived dendritic cells are pivotal in Th17 pathogenesis. J. Immunol. 2014. 192: 2202-2209.
Saito, Y., Respatika, D., Komori, S., Washio, K., Nishimura, T., Kotani, T., Murata, Y. et al., SIRPα+ dendritic cells regulate homeostasis of fibroblastic reticular cells via TNF receptor ligands in the adult spleen. Proc. Natl. Acad. Sci. USA. 2017. 114: E10151-E10160.
Han, M. H., Lundgren, D. H., Jaiswal, S., Chao, M., Graham, K. L., Garris, C. S., Axtell, R. C. et al., Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice. J. Exp. Med. 2012. 209:1325-1334.
Satpathy, A. T., Briseño, C. G., Lee, J. S., Ng, D., Manieri, N. A., KC, W., Wu, X. et al., Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens. Nat. Immunol. 2013. 14: 937-948.
Durai, V. and Murphy, K. M., Functions of murine dendritic cells. Immunity. 2016. 45: 719-736.
Mashayekhi, M., Sandau, M. M., Dunay, I. R., Frickel, E. M., Khan, A., Goldszmid, R. S., Sher, A. et al., CD8α+ dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity 2011. 35: 249-259.
Suzuki, S., Honma, K., Toriyama, K., Akitoyo, I., Suematsu, T., Nakamura, M., Kumatori, A., Critical roles of interferon regulatory factor 4 in CD11bhighCD8α− dendritic cell development. Proc. Natl. Acad. Sci. USA. 2004. 101: 8981-8986.
Brüstle, A., Heink, S., Huber, M., Rosenplänter, C., Stadelmann, C., Yu, P., Arpaia, E. et al., Development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 2007. 8: 958-966.
Persson, E. K., Uronen-Hansson, H., Semmrich, M., Rivollier, A, Hägerbrand, K., Marsal, J., Gudjonsson, S. et al., IRF4 transcription-factor-dependent CD103+CD11b+ dendritic cells drive mucosal T helper 17 cell differentiation. Immunity 2013. 38: 958-969.
Jordão, M. J. C., Sankowski, R., Brendecke, S. M., Sagar, Locatelli, G., Tai, Y-H., Tay, T. L. et al., Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation. Science 2019. 363: eaat7554.
Croxford, A. L., Lanzinger, M., Hartmann, F. J., Schreiner, B., Mair, F., Pelczar, P., Clausen, B. E. et al., The cytokine GM-CSF drives the inflammatory signature of CCR2+ monocytes and licenses autoimmunity. Immunity 2015. 43: 502-514.
Saito, Y., Iwamura, H., Kaneko, T., Ohnishi, H., Murata, Y., Okazawa, H., Kanazawa, Y. et al., Regulation by SIRPα of dendritic cell homeostasis in lymphoid tissues. Blood 2010. 116: 3517-3525.
Sato-Hashimoto, M., Nozu, T., Toriba, R., Horikoshi, A., Akaike, M., Kawamoto, K., Hirose, A. et al., Microglial SIRPα regulates the emergence of CD11c+ microglia and demyelination damage in white matter. Elife 2019. 8: e42025.
Ticchioni, M., Lamy, L., Wijdenes, J., Lindberg, F. P., Brown, E. J. and Bernard, A., Integrin-associated protein (CD47/IAP) contributes to T cell arrest on inflammatory vascular endothelium under flow. FASEB J. 2001. 15: 341-350.
de Vries, H. E., Hendriks, J. J. A., Honing, H., de Lavalette, C. R., van der Pol, S. M. A., Hooijberg, E., Dijkstra, C. D. et al., Signal-regulatory protein alpha-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium. J. Immunol. 2002. 168: 5832-5839.
Gao, Q., Zhang, Y., Han, C., Hu, X., Zhang, H., Xu, X., Tian, J. et al., Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells. J. Autoimmun. 2016. 69: 74-85.
Croxford, A. L., Spath, S. and Becher, B., GM-CSF in neuroinflammation: licensing myeloid cells for tissue damage. Trends Immunol. 2015. 36: 651-662.
Yanagita, T., Murata, Y., Tanaka, D., Motegi, S-I., Arai, E., Daniwijaya, E.W., Hazama, D. et al., Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy. JCI Insight. 2017. 2: e89140.
Murata, Y., Tanaka, D., Hazama, D., Yanagita, T., Saito, Y., Kotani, T., Oldenborg, P. -A. et al., Anti-human SIRPα antibody is a new tool for cancer immunotherapy. Cancer Sci. 2018. 109: 1300-1308.
Matsushita, T., Fujimoto, M., Hasegawa, M., Komura, K., Takehara, K., Tedder, T .F. and Sato, S., Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. Am. J. Pathol. 2006. 168: 812-821.
Cossarizza, A., Chang, H. D., Radbruch, A., Acs, A., Adam, A., Adam-Klages, S., Agace, W. et al., Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). Eur. J. Immunol. 2019. 49: 1457-1973.

Auteurs

Taichi Nishimura (T)

Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan.
Division of Anesthesiology, Department of Surgery Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan.

Yasuyuki Saito (Y)

Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan.

Ken Washio (K)

Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan.

Satomi Komori (S)

Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan.

Datu Respatika (D)

Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan.
Division of Reconstruction, Oculoplasty, and Oncology, Department of Ophthalmology, Faculty of Medicine, Public Health, and Nursing, Gadjah Mada University, Yogyakarta, Indonesia.

Takenori Kotani (T)

Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan.

Yoji Murata (Y)

Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan.

Hiroshi Ohnishi (H)

Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Gunma, Japan.

Satoshi Mizobuchi (S)

Division of Anesthesiology, Department of Surgery Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan.

Takashi Matozaki (T)

Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH